Research + Publications

Research + Publications

Primary analysis of phase 2 results for cemiplimab, a human...

BACKGROUND: CSCC is rivaled only by basal cell carcinoma as the most common cancer Read more >

Primary analysis of phase 2 results for cemiplimab, a human monoclonal anti-PD-1, in patients with metastatic cutaneous squamous cell carcinoma (mCSCC).2018-10-03T22:01:51+00:00
Research + Publications

Handling missing values in real world data: are there...

Purpose: Section 3022 of the 21st Century Cures Act directs FDA to evaluate and Read more >

Handling missing values in real world data: are there challenges for regulatory decisions on medical products? Poster presented at the ISPOR 23rd Annual International Meeting; 2018 May 19-23.2018-10-03T19:52:11+00:00
Research + Publications

Cost per response of certolizumab pegol versus adalimumab...

BACKGROUND: Biologics are effective in managing rheumatoid arthritis (RA) but switching as early as Read more >

Cost per response of certolizumab pegol versus adalimumab among biologic-naïve patients with moderate or severe rheumatoid arthritis from the us payer. Poster presented at the ISPOR 23rd Annual International Meeting.2018-10-02T22:20:44+00:00
Research + Publications

Development of a Framework Based on Reflective MCDA to...

INTRODUCTION: Well- or moderately differentiated gastroenteropancreatic neuroendocrine tumors (GEP-NETs) are often slow-growing, and some Read more >

Development of a Framework Based on Reflective MCDA to Support Patient-Clinician Shared Decision-Making: The Case of the Management of Gastroenteropancreatic Neuroendocrine Tumors (GEP-NET) in the United States2018-02-22T14:33:48+00:00
Research + Publications

Cabozantinib versus everolimus, nivolumab, axitinib,...

BACKGROUND: Relative effect of therapies indicated for the treatment of advanced renal cell carcinoma Read more >

Cabozantinib versus everolimus, nivolumab, axitinib, sorafenib and best supportive care: A network meta-analysis of progression-free survival and overall survival in second line treatment of advanced renal cell carcinoma.2018-02-22T14:58:41+00:00
Research + Publications

Antiepileptic drugs and risk of suicide attempts: a...

Abstract: PURPOSE: Randomized-controlled trials and claims databases suggest that antiepileptic drug (AED) use may increase Read more >

Antiepileptic drugs and risk of suicide attempts: a case-control study exploring the impact of underlying medical conditions.2018-02-05T11:30:41+00:00